Publication In " Journal Of Autoimmunity" For Its Anti-Inflammatory Compound, Amilo-5Mer

Eocene

19/08/2021 13:20

Aug 19 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS LTD - PUBLICATION IN " JOURNAL OF
AUTOIMMUNITY" FOR ITS IND READY, AMILO-5MER, A SPECIFIC
ANTI-INFLAMMATORY COMPOUND
    * GALMED PHARMACEUTICALS LTD - AMILO-5MER SUPPRESSES CHRONIC
INFLAMMATIONS IN BROAD SPECTRUM OF ANIMAL MODELS OF INFLAMMATORY
DISEASES
    * GALMED PHARMACEUTICALS LTD - AMILO-5MER HAS A UNIQUE
MECHANISM
OF ACTION TARGETING SERUM AMYLOID A (SAA) ASSOCIATED PATHOLOGIES

Source text for Eikon:  ID:nPn64Hklqa 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))